nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Photosensitivity—Epirubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Verteporfin—Loss of consciousness—Irinotecan—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Verteporfin—Malaise—Gemcitabine—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Verteporfin—Cough—Irinotecan—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Verteporfin—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Myocardial infarction—Docetaxel—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Hypertension—Irinotecan—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Eczema—Epirubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Conjunctivitis—Docetaxel—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Cough—Gemcitabine—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Verteporfin—Pain—Sunitinib—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Verteporfin—Constipation—Sunitinib—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Verteporfin—Discomfort—Irinotecan—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Hypertension—Gemcitabine—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Asthenia—Tamoxifen—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Verteporfin—Arthralgia—Gemcitabine—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Verteporfin—Chest pain—Gemcitabine—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Verteporfin—Asthenia—Erlotinib—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Verteporfin—Discomfort—Gemcitabine—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Pruritus—Tamoxifen—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Oedema—Irinotecan—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Photosensitivity—Doxorubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Chest pain—Fluorouracil—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Pruritus—Erlotinib—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Discomfort—Fluorouracil—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Verteporfin—Shock—Irinotecan—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Nervous system disorder—Irinotecan—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Haemoglobin—Docetaxel—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Verteporfin—Eczema—Doxorubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Verteporfin—Oedema—Gemcitabine—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Verteporfin—Haemorrhage—Docetaxel—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Verteporfin—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Pharyngitis—Docetaxel—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Body temperature increased—Sunitinib—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Oedema—Fluorouracil—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Verteporfin—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Verteporfin—Osteoarthritis—Epirubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Verteporfin—Diplopia—Epirubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Verteporfin—Skin disorder—Gemcitabine—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Verteporfin—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Verteporfin—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Verteporfin—Visual impairment—Docetaxel—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Verteporfin—Dizziness—Tamoxifen—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Verteporfin—Dizziness—Erlotinib—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Verteporfin—Eye disorder—Docetaxel—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Verteporfin—Cardiac disorder—Docetaxel—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Verteporfin—Flushing—Docetaxel—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Verteporfin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Rash—Tamoxifen—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Dermatitis—Tamoxifen—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Dyspnoea—Irinotecan—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Headache—Tamoxifen—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Rash—Erlotinib—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Verteporfin—Dermatitis—Erlotinib—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Verteporfin—Angiopathy—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Verteporfin—Immune system disorder—Docetaxel—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Headache—Erlotinib—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Osteoarthritis—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Diplopia—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Liver function test abnormal—Epirubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Asthenia—Sunitinib—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Dyspnoea—Gemcitabine—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Verteporfin—Pruritus—Sunitinib—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Verteporfin—Constipation—Irinotecan—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Verteporfin—Pain—Irinotecan—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Verteporfin—Dyspnoea—Fluorouracil—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Verteporfin—Malnutrition—Docetaxel—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Nausea—Tamoxifen—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Muscular weakness—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Pain—Gemcitabine—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Constipation—Gemcitabine—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Nausea—Erlotinib—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Feeling abnormal—Irinotecan—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Influenza—Epirubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Verteporfin—Back pain—Docetaxel—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Verteporfin—Pain—Fluorouracil—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Verteporfin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Dizziness—Sunitinib—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Body temperature increased—Irinotecan—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Verteporfin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Verteporfin—Anaemia—Docetaxel—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Muscular weakness—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Verteporfin—Body temperature increased—Gemcitabine—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Rash—Sunitinib—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Dermatitis—Sunitinib—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Urticaria—Fluorouracil—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Headache—Sunitinib—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Syncope—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Verteporfin—Loss of consciousness—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Verteporfin—Cough—Docetaxel—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Verteporfin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Hypertension—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Arthralgia—Docetaxel—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Chest pain—Docetaxel—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Nausea—Sunitinib—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Asthenia—Irinotecan—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Sweating—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Verteporfin—Asthenia—Gemcitabine—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Verteporfin—Oedema—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Verteporfin—Pruritus—Gemcitabine—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Shock—Docetaxel—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Nervous system disorder—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Pruritus—Fluorouracil—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Skin disorder—Docetaxel—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Verteporfin—Dizziness—Irinotecan—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—pancreatic cancer	0.000998	0.000998	CcSEcCtD
Verteporfin—Dizziness—Fluorouracil—pancreatic cancer	0.000974	0.000974	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—pancreatic cancer	0.000973	0.000973	CcSEcCtD
Verteporfin—Rash—Irinotecan—pancreatic cancer	0.00097	0.00097	CcSEcCtD
Verteporfin—Dermatitis—Irinotecan—pancreatic cancer	0.000969	0.000969	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000969	0.000969	CcSEcCtD
Verteporfin—Headache—Irinotecan—pancreatic cancer	0.000964	0.000964	CcSEcCtD
Verteporfin—Dyspnoea—Docetaxel—pancreatic cancer	0.000948	0.000948	CcSEcCtD
Verteporfin—Rash—Gemcitabine—pancreatic cancer	0.000945	0.000945	CcSEcCtD
Verteporfin—Dermatitis—Gemcitabine—pancreatic cancer	0.000944	0.000944	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—pancreatic cancer	0.000944	0.000944	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000939	0.000939	CcSEcCtD
Verteporfin—Headache—Gemcitabine—pancreatic cancer	0.000939	0.000939	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000937	0.000937	CcSEcCtD
Verteporfin—Flushing—Epirubicin—pancreatic cancer	0.000937	0.000937	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000934	0.000934	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00093	0.00093	CcSEcCtD
Verteporfin—Rash—Fluorouracil—pancreatic cancer	0.000929	0.000929	CcSEcCtD
Verteporfin—Dermatitis—Fluorouracil—pancreatic cancer	0.000928	0.000928	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000927	0.000927	CcSEcCtD
Verteporfin—Headache—Fluorouracil—pancreatic cancer	0.000923	0.000923	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000918	0.000918	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Verteporfin—Nausea—Irinotecan—pancreatic cancer	0.000914	0.000914	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—pancreatic cancer	0.000912	0.000912	CcSEcCtD
Verteporfin—Pain—Docetaxel—pancreatic cancer	0.00091	0.00091	CcSEcCtD
Verteporfin—Constipation—Docetaxel—pancreatic cancer	0.00091	0.00091	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—pancreatic cancer	0.0009	0.0009	CcSEcCtD
Verteporfin—Nausea—Gemcitabine—pancreatic cancer	0.00089	0.00089	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—pancreatic cancer	0.000879	0.000879	CcSEcCtD
Verteporfin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Verteporfin—Nausea—Fluorouracil—pancreatic cancer	0.000875	0.000875	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—pancreatic cancer	0.000873	0.000873	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—pancreatic cancer	0.000867	0.000867	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000867	0.000867	CcSEcCtD
Verteporfin—Back pain—Epirubicin—pancreatic cancer	0.00085	0.00085	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—pancreatic cancer	0.000848	0.000848	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000844	0.000844	CcSEcCtD
Verteporfin—Body temperature increased—Docetaxel—pancreatic cancer	0.000841	0.000841	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—pancreatic cancer	0.000828	0.000828	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000816	0.000816	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—pancreatic cancer	0.000813	0.000813	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—pancreatic cancer	0.000812	0.000812	CcSEcCtD
Verteporfin—Malaise—Epirubicin—pancreatic cancer	0.000793	0.000793	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Verteporfin—Syncope—Epirubicin—pancreatic cancer	0.000788	0.000788	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Verteporfin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000784	0.000784	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000773	0.000773	CcSEcCtD
Verteporfin—Cough—Epirubicin—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Verteporfin—Asthenia—Docetaxel—pancreatic cancer	0.000763	0.000763	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—pancreatic cancer	0.000759	0.000759	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000755	0.000755	CcSEcCtD
Verteporfin—Pruritus—Docetaxel—pancreatic cancer	0.000753	0.000753	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—pancreatic cancer	0.000752	0.000752	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—pancreatic cancer	0.000748	0.000748	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—pancreatic cancer	0.000748	0.000748	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000743	0.000743	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—pancreatic cancer	0.000739	0.000739	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—pancreatic cancer	0.000733	0.000733	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—pancreatic cancer	0.000731	0.000731	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—pancreatic cancer	0.000729	0.000729	CcSEcCtD
Verteporfin—Oedema—Epirubicin—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000715	0.000715	CcSEcCtD
Verteporfin—Cough—Doxorubicin—pancreatic cancer	0.00071	0.00071	CcSEcCtD
Verteporfin—Shock—Epirubicin—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000704	0.000704	CcSEcCtD
Verteporfin—Dizziness—Docetaxel—pancreatic cancer	0.000703	0.000703	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—pancreatic cancer	0.000702	0.000702	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—pancreatic cancer	0.000697	0.000697	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000694	0.000694	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—pancreatic cancer	0.000692	0.000692	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—pancreatic cancer	0.000692	0.000692	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000688	0.000688	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—pancreatic cancer	0.000684	0.000684	CcSEcCtD
Verteporfin—Rash—Docetaxel—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Verteporfin—Dermatitis—Docetaxel—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Verteporfin—Headache—Docetaxel—pancreatic cancer	0.000666	0.000666	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—pancreatic cancer	0.000664	0.000664	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000654	0.000654	CcSEcCtD
Verteporfin—Shock—Doxorubicin—pancreatic cancer	0.000653	0.000653	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000651	0.000651	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000642	0.000642	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—pancreatic cancer	0.00064	0.00064	CcSEcCtD
Verteporfin—Nausea—Docetaxel—pancreatic cancer	0.000632	0.000632	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000619	0.000619	CcSEcCtD
Verteporfin—Pain—Epirubicin—pancreatic cancer	0.000613	0.000613	CcSEcCtD
Verteporfin—Constipation—Epirubicin—pancreatic cancer	0.000613	0.000613	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000605	0.000605	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000592	0.000592	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—pancreatic cancer	0.000568	0.000568	CcSEcCtD
Verteporfin—Pain—Doxorubicin—pancreatic cancer	0.000568	0.000568	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—pancreatic cancer	0.000567	0.000567	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000547	0.000547	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000529	0.000529	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—pancreatic cancer	0.000527	0.000527	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000525	0.000525	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—pancreatic cancer	0.000515	0.000515	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—pancreatic cancer	0.000508	0.000508	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000489	0.000489	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—pancreatic cancer	0.000476	0.000476	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—pancreatic cancer	0.000474	0.000474	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—pancreatic cancer	0.00047	0.00047	CcSEcCtD
Verteporfin—Rash—Epirubicin—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Verteporfin—Headache—Epirubicin—pancreatic cancer	0.000449	0.000449	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Verteporfin—Nausea—Epirubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Verteporfin—Rash—Doxorubicin—pancreatic cancer	0.000419	0.000419	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—pancreatic cancer	0.000418	0.000418	CcSEcCtD
Verteporfin—Headache—Doxorubicin—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—pancreatic cancer	0.000394	0.000394	CcSEcCtD
